「ma」の検索結果
176件：36～40件目を表示
-
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
General Announcement: May 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion S...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf -
General Announcement: May 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion S...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
Quality Policies | About Senju | SENJU Pharmaceutical
s We always pay close attention to the quality of our products to provide customers with better pharmaceuticals and comply with laws and standards with high ethical standards on product quality, and e...
http://www.senju.co.jp/english/about/quality.html -
Mytear EYETECT ALPITATTO N | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® EYETECT® ALPITATTON Works on unpleasant eye itching due to pollens and ...
http://www.senju.co.jp/english/products/apn.html